US FDA clears diabetes drug for treatment of obesity

The US Food and Drug Administration (FDA) has approved diabetes drug Liraglutide (Saxenda, Novo Nordisk) for the treatment of obesity.

Main Topic: 
Name of the Newspaper: 
Mark Content Private(Internal): 
Clipping Type: 
DNB
External URL: 
http://www.asianage.com/india/us-fda-clears-diabetes-drug-treatment-obesity-799
Publication Date: 
25/12/2014